Abstract
Outcomes for Patients with Relapsed and Refractory Peripheral T-Cell Lymphoma in the 21st Century By Relapse Status, Salvage Therapy, and Receipt of Allogeneic Transplant
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have